SHOULDER INNOVATIONS, INC. Accounts Payable
SHOULDER INNOVATIONS, INC. (SI) had Accounts Payable of $5.93 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $5.93M.
- 2026-03-31: Accounts Payable, Current $5.92M.
- 2025-12-31: Accounts Payable, Current $8.87M.
- 2025-09-30: Accounts Payable, Current $8.88M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $5.93M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $5.92M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $8.87M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $8.88M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $6.04M 10-Q · filed 2025-09-09 |
| 2024-12-31 | $4.86M 10-K · filed 2026-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |